{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:50:47Z","timestamp":1772272247285,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,15]],"date-time":"2015-05-15T00:00:00Z","timestamp":1431648000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DFG Excellence Cluster","award":["DFG EXC 306\/1 and 2"],"award-info":[{"award-number":["DFG EXC 306\/1 and 2"]}]},{"name":"GRK","award":["GRK1727\/1"],"award-info":[{"award-number":["GRK1727\/1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13023-015-0278-x","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T09:02:31Z","timestamp":1434618151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Prevalence of pemphigus and pemphigoid autoantibodies in the general population"],"prefix":"10.1186","volume":"10","author":[{"given":"Wiebke","family":"Pr\u00fc\u00dfmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasper","family":"Pr\u00fc\u00dfmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Koga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Recke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siegfried","family":"G\u00f6rg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard","family":"Henschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saleh M.","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf J.","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,5,15]]},"reference":[{"key":"278_CR1","doi-asserted-by":"publisher","first-page":"a180","DOI":"10.1136\/bmj.a180","volume":"337","author":"SM Langan","year":"2008","unstructured":"Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ, West J. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ. 2008;337:a180.","journal-title":"BMJ"},{"key":"278_CR2","first-page":"434","volume":"7","author":"F Bertram","year":"2009","unstructured":"Bertram F, Brocker EB, Zillikens D, Schmidt E. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany. J Dtsch Dermatol Ges. 2009;7:434\u201340.","journal-title":"J Dtsch Dermatol Ges"},{"key":"278_CR3","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1111\/j.1365-2133.2011.10413.x","volume":"165","author":"B Cortes","year":"2011","unstructured":"Cortes B, Marazza G, Naldi L, Combescure C, Borradori L. Mortality of bullous pemphigoid in Switzerland: a prospective study. Br J Dermatol. 2011;165:368\u201374.","journal-title":"Br J Dermatol"},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/jid.2012.35","volume":"132","author":"P Joly","year":"2012","unstructured":"Joly P, Baricault S, Sparsa A, Bernard P, Bedane C, Duvert-Lehembre S, et al. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol. 2012;132:1998\u20132004.","journal-title":"J Invest Dermatol"},{"key":"278_CR5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1600-0625.2005.00367.x","volume":"14","author":"C Sitaru","year":"2005","unstructured":"Sitaru C, Zillikens D. Mechanisms of blister induction by autoantibodies. Exp Dermatol. 2005;14:861\u201375.","journal-title":"Exp Dermatol"},{"key":"278_CR6","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.molmed.2013.06.003","volume":"19","author":"RJ Ludwig","year":"2013","unstructured":"Ludwig RJ, Kalies K, K\u00f6hl J, Zillikens D, Schmidt E. Emerging treatments for pemphigoid diseases. Trends Mol Med. 2013;19:501\u201312.","journal-title":"Trends Mol Med"},{"key":"278_CR7","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1056\/NEJMra061111","volume":"355","author":"JR Stanley","year":"2006","unstructured":"Stanley JR, Amagai M. Pemphigus, bullous impetigo, and the staphylococcal scalded-skin syndrome. N Engl J Med. 2006;355:1800\u201310.","journal-title":"N Engl J Med"},{"key":"278_CR8","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","volume":"381","author":"E Schmidt","year":"2013","unstructured":"Schmidt E, Zillikens D. Pemphigoid diseases. Lancet. 2013;381:320\u201332.","journal-title":"Lancet"},{"key":"278_CR9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1001\/archderm.131.8.957","volume":"131","author":"D Zillikens","year":"1995","unstructured":"Zillikens D, Wever S, Roth A, Weidenthaler-Barth B, Hashimoto T, Brocker EB. Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol. 1995;131:957\u20138.","journal-title":"Arch Dermatol"},{"key":"278_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archderm.1995.01690130050009","volume":"131","author":"P Bernard","year":"1995","unstructured":"Bernard P, Vaillant L, Labeille B, Bedane C, Arbeille B, Denoeux JP, et al. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Arch Dermatol. 1995;131:48\u201352.","journal-title":"Arch Dermatol"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","volume":"41","author":"M Jung","year":"1999","unstructured":"Jung M, Kippes W, Messer G, Zillikens D, Rzany B. Increased risk of bullous pemphigoid in male and very old patients: A population-based study on incidence. J Am Acad Dermatol. 1999;41:266\u20138.","journal-title":"J Am Acad Dermatol"},{"key":"278_CR12","first-page":"317","volume":"15","author":"E Cozzani","year":"2001","unstructured":"Cozzani E, Parodi A, Rebora A, Delmonte S, Barile M, Nigro A, et al. Bullous pemphigoid in Liguria: a 2-year survey. J Eur Acad Dermatol Venereol. 2001;15:317\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"278_CR13","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","volume":"153","author":"VS Gudi","year":"2005","unstructured":"Gudi VS, White MI, Cruickshank N, Herriot R, Edwards SL, Nimmo F, et al. Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol. 2005;153:424\u20137.","journal-title":"Br J Dermatol"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/1523-1747.ep12612836","volume":"104","author":"S Bastuji-Garin","year":"1995","unstructured":"Bastuji-Garin S, Souissi R, Blum L, Turki H, Nouira R, Jomaa B, et al. Comparative epidemiology of pemphigus in Tunisia and France: unusual incidence of pemphigus foliaceus in young Tunisian women. J Invest Dermatol. 1995;104:302\u20135.","journal-title":"J Invest Dermatol"},{"key":"278_CR15","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","volume":"161","author":"G Marazza","year":"2009","unstructured":"Marazza G, Pham HC, Scharer L, Pedrazzetti PP, Hunziker T, Trueb RM, et al. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study. Br J Dermatol. 2009;161:861\u20138.","journal-title":"Br J Dermatol"},{"key":"278_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1365-4362.2000.00864.x","volume":"39","author":"N Tsankov","year":"2000","unstructured":"Tsankov N, Vassileva S, Kamarashev J, Kazandjieva J, Kuzeva V. Epidemiology of pemphigus in Sofia, Bulgaria. A 16\u2014year retrospective study (1980\u20131995). Int J Dermatol. 2000;39:104\u20138.","journal-title":"Int J Dermatol"},{"key":"278_CR17","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1056\/NEJMoa021933","volume":"349","author":"MR Arbuckle","year":"2003","unstructured":"Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526\u201333.","journal-title":"N Engl J Med"},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1002\/art.11223","volume":"48","author":"S Rantapaa-Dahlqvist","year":"2003","unstructured":"Rantapaa-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741\u20139.","journal-title":"Arthritis Rheum"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1600-0625.2007.00592.x","volume":"16","author":"C Sitaru","year":"2007","unstructured":"Sitaru C, Dahnrich C, Probst C, Komorowski L, Blocker I, Schmidt E, et al. Enzyme\u2014linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies. Exp Dermatol. 2007;16:770\u20137.","journal-title":"Exp Dermatol"},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1600-0625.2010.01069.x","volume":"19","author":"E Schmidt","year":"2010","unstructured":"Schmidt E, Dahnrich C, Rosemann A, Probst C, Komorowski L, Saschenbrecker S, et al. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients. Exp Dermatol. 2010;19:458\u201363.","journal-title":"Exp Dermatol"},{"key":"278_CR21","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/jid.2010.230","volume":"30","author":"X Yu","year":"2010","unstructured":"Yu X, Holdorf K, Kasper B, Zillikens D, Ludwig RJ, Petersen F. FcgammaRIIA and FcgammaRIIIB Are Required for Autoantibody\u2014Induced Tissue Damage in Experimental Human Models of Bullous Pemphigoid. J Invest Dermatol. 2010;30:2841\u20134.","journal-title":"J Invest Dermatol"},{"key":"278_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jdermsci.2011.11.012","volume":"65","author":"J Dworschak","year":"2012","unstructured":"Dworschak J, Recke A, Freitag M, Ludwig RJ, Langenhan J, Kreuzer OJ, et al. Mapping of B cell epitopes on desmoglein 3 in pemphigus vulgaris patients by the use of overlapping peptides. J Dermatol Sci. 2012;65:102\u20139.","journal-title":"J Dermatol Sci"},{"key":"278_CR23","doi-asserted-by":"publisher","first-page":"2480","DOI":"10.1172\/JCI116856","volume":"92","author":"Z Liu","year":"1993","unstructured":"Liu Z, Diaz LA, Troy JL, Taylor AF, Emery DJ, Fairley JA, et al. A passive transfer model of the organ\u2014specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest. 1993;92:2480\u20138.","journal-title":"J Clin Invest"},{"key":"278_CR24","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nm1496","volume":"13","author":"W Nishie","year":"2007","unstructured":"Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, et al. Humanization of autoantigen. Nat Med. 2007;13:378\u201383.","journal-title":"Nat Med"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.4049\/jimmunol.1100596","volume":"187","author":"M Hirose","year":"2011","unstructured":"Hirose M, Recke A, Beckmann T, Shimizu A, Ishiko A, Bieber K, et al. Repetitive Immunization Breaks Tolerance to Type XVII Collagen and Leads to Bullous Pemphigoid in Mice. J Immunol. 2011;187:1176\u201383.","journal-title":"J Immunol"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"ra23","DOI":"10.1126\/scisignal.2001617","volume":"4","author":"S Kulkarni","year":"2011","unstructured":"Kulkarni S, Sitaru C, Andersson KE, Jakus Z, Davidson K, Hirose M, et al. Essential role for PI3K\u03b2 in neutrophil activation by immune complexes. Sci Signal. 2011;4:ra23.","journal-title":"Sci Signal"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1046\/j.1523-1747.2003.12017.x","volume":"120","author":"SJ Warren","year":"2003","unstructured":"Warren SJ, Arteaga LA, Rivitti EA, Aoki V, Hans-Filho G, Qaqish BF, et al. The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol. 2003;120:104\u20138.","journal-title":"J Invest Dermatol"},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1084\/jem.20022031","volume":"197","author":"N Li","year":"2003","unstructured":"Li N, Aoki V, Hans-Filho G, Rivitti EA, Diaz LA. The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem). J Exp Med. 2003;197:1501\u201310.","journal-title":"J Exp Med"},{"key":"278_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/1523-1747.ep12337492","volume":"109","author":"D Zillikens","year":"1997","unstructured":"Zillikens D, Rose PA, Balding SD, Liu Z, Olague-Marchan M, Diaz LA, et al. Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol. 1997;109:573\u20139.","journal-title":"J Invest Dermatol"},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1046\/j.1523-1747.2000.00153.x","volume":"115","author":"MS Lin","year":"2000","unstructured":"Lin MS, Fu CL, Giudice GJ, Olague-Marchan M, Lazaro AM, Stastny P, et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol. 2000;115:955\u201361.","journal-title":"J Invest Dermatol"},{"key":"278_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","volume":"29","author":"WW Eaton","year":"2007","unstructured":"Eaton WW, Rose NR, Kalaydjian A, Pedersen MG, Mortensen PB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun. 2007;29:1\u20139.","journal-title":"J Autoimmun"},{"key":"278_CR32","first-page":"423","volume":"144","author":"L Heimbach","year":"2009","unstructured":"Heimbach L, Li N, Diaz A, Liu Z. Experimental animal models of bullous pemphigoid. G Ital Dermatol Venereol. 2009;144:423\u201331.","journal-title":"G Ital Dermatol Venereol"},{"key":"278_CR33","first-page":"577","volume":"42","author":"R Dopp","year":"2000","unstructured":"Dopp R, Schmidt E, Chimanovitch I, Leverkus M, Brocker EB, Zillikens D. IgG4 and IgE are the major immunoglobulins targeting the NC16A domain of BP180 in Bullous pemphigoid: serum levels of these immunoglobulins reflect disease activity. J Am Acad Dermatol. 2000;42:577\u201383.","journal-title":"J Am Acad Dermatol"},{"key":"278_CR34","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1056\/NEJM198906013202206","volume":"320","author":"B Rock","year":"1989","unstructured":"Rock B, Martins CR, Theofilopoulos AN, Balderas RS, Anhalt GJ, Labib RS, et al. The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med. 1989;320:1463\u20139.","journal-title":"N Engl J Med"},{"key":"278_CR35","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","volume":"159","author":"K Ishii","year":"1997","unstructured":"Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, et al. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol. 1997;159:2010\u20137.","journal-title":"J Immunol"},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/1523-1747.ep12338088","volume":"109","author":"D Zillikens","year":"1997","unstructured":"Zillikens D, Mascaro JM, Rose PA, Liu Z, Ewing SM, Caux F, et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol. 1997;109:679\u201383.","journal-title":"J Invest Dermatol"},{"key":"278_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/S0923-1811(02)00109-3","volume":"30","author":"M Kobayashi","year":"2002","unstructured":"Kobayashi M, Amagai M, Kuroda-Kinoshita K, Hashimoto T, Shirakata Y, Hashimoto K, et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci. 2002;30:224\u201332.","journal-title":"J Dermatol Sci"},{"key":"278_CR38","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1111\/j.1440-0960.2008.00452.x","volume":"49","author":"N Desai","year":"2008","unstructured":"Desai N, Allen J, Ali I, Venning V, Wojnarowska F. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting. Australas J Dermatol. 2008;49:137\u201341.","journal-title":"Australas J Dermatol"},{"key":"278_CR39","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jdermsci.2005.11.002","volume":"41","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Hamada T, Amagai M, Hashimoto K, Uehara R, Yamaguchi K, et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci. 2006;41:21\u201330.","journal-title":"J Dermatol Sci"},{"key":"278_CR40","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.clim.2003.12.007","volume":"111","author":"A Kromminga","year":"2004","unstructured":"Kromminga A, Sitaru C, Hagel C, Herzog S, Zillikens D. Development of an ELISA for the detection of autoantibodies to BP230. Clin Immunol. 2004;111:146\u201352.","journal-title":"Clin Immunol"},{"key":"278_CR41","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/j.1365-2133.2012.10820.x","volume":"166","author":"IM Blocker","year":"2012","unstructured":"Blocker IM, Dahnrich C, Probst C, Komorowski L, Saschenbrecker S, Schlumberger W, et al. Epitope mapping of BP230 leading to a novel enzyme-linked immunosorbent assay for autoantibodies in bullous pemphigoid. Br J Dermatol. 2012;166:964\u201370.","journal-title":"Br J Dermatol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0278-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-015-0278-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0278-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-015-0278-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T15:23:45Z","timestamp":1691767425000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-015-0278-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,15]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s13023-015-0278-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,15]]},"assertion":[{"value":"20 February 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"63"}}